Literature DB >> 11267181

Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function.

A Salazar1, V C McAlister, B A Kiberd, H Bitter-Suermann, M F Al-Kerithy, A S MacDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267181     DOI： 10.1016/s0041-1345(00)02321-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C A Vivas; A Jain; T R Hakala; J McCauley; J Johnston; P Randhawa; S Fedorek; E Gray; A Chesky; I Dvorchik; J Donaldson; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  2002-08       Impact factor: 1.066

Review 2.  Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer?

Authors:  Francesca M Egidi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Rapamycin unbalances the polarization of human macrophages to M1.

Authors:  Alessia Mercalli; Ines Calavita; Erica Dugnani; Antonio Citro; Elisa Cantarelli; Rita Nano; Raffaella Melzi; Paola Maffi; Antonio Secchi; Valeria Sordi; Lorenzo Piemonti
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

4.  Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.

Authors:  G Ciancio; J Sageshima; L Chen; J J Gaynor; L Hanson; L Tueros; E Montenora-Velarde; C Gomez; W Kupin; G Guerra; A Mattiazzi; A Fornoni; A Pugliese; D Roth; M Wolf; G W Burke
Journal:  Am J Transplant       Date:  2012-09-04       Impact factor: 8.086
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.